K.RichardsJ
The extraordinary therapeutic promise of GLP1 receptor agonists underscores a powerful irony: the very mechanisms that make these drugs so effective across multiple organ systems are already built into the human body, waiting to be activated by the right food, not just a needle
Includes: 5 Learning Modules, 12 Week Guided Action Plan, Recipes, Meal Plans, Resources & Tracking Tools 3I Framework for Mindset & Goal Setting Biofeedback & The 4Ps: Customize for Your Body & Your Lifestyle The Health First Approach to Metabolism Mindful & Intuitive Eating The AIM Method: Awareness, Adaptation & Integration 12 Week Guided Action Plan: Build Your Wellness Roadmap Recipes & Meal Plans: 650+ Recipes & Meal Plans Tools & Resources - Habit trackers, reflection exercises, and implementation guides
An NDA submission is expected in Q4 2026
Research into tirzepatide has focused on its complementary receptor activity GLP-1 agonism driving appetite suppression and insulin secretion while GIP agonism contributes to improved insulin sensitivity and potentially favorable effects on adipose tissue metabolism
With the obesity epidemic contributing to rising rates of diabetes, heart disease and other chronic conditions, GLP-1 therapies represent a potential turning point in the fight against these diseases